HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oksana Berezovska Selected Research

Presenilins

1/2017Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β production.
1/2014Structural interactions between inhibitor and substrate docking sites give insight into mechanisms of human PS1 complexes.
2/2013Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease.
3/2011Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation.
11/2009Allosteric modulation of PS1/gamma-secretase conformation correlates with amyloid beta(42/40) ratio.
3/2005Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein.
6/2003Monitoring proteins in intact cells.
6/2003Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging.
1/2003Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oksana Berezovska Research Topics

Disease

38Alzheimer Disease (Alzheimer's Disease)
06/2022 - 08/2002
2Parkinson Disease (Parkinson's Disease)
07/2014 - 06/2008
2Neoplasms (Cancer)
01/2014 - 05/2009
1Synucleinopathies
07/2014
1Dementia (Dementias)
07/2014
1Encephalitis (Encephalitis, Rasmussen)
02/2013
1Amyloid Plaque
07/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
05/2011
1Huntington Disease (Huntington's Disease)
05/2011
1Neuroblastoma
03/2011

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2003
18Amyloid (Amyloid Fibrils)IBA
06/2022 - 06/2003
16Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2022 - 08/2002
11Presenilin-1IBA
06/2022 - 03/2004
9Peptides (Polypeptides)IBA
06/2022 - 10/2005
9PresenilinsIBA
01/2017 - 01/2003
5Amyloid beta-PeptidesIBA
11/2009 - 08/2002
2Flavin-Adenine Dinucleotide (FAD)IBA
05/2021 - 03/2005
2Apolipoproteins E (ApoE)IBA
01/2017 - 09/2004
2ApolipoproteinsIBA
01/2017 - 09/2004
2alpha-SynucleinIBA
07/2014 - 06/2008
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2017
1CalciumIBA
03/2016
1SynucleinsIBA
07/2014
1polyglutamineIBA
05/2011
1Huntingtin ProteinIBA
05/2011
1DNA (Deoxyribonucleic Acid)IBA
10/2006
1Amino AcidsFDA Link
10/2005
1Presenilin-2IBA
03/2004
1EnzymesIBA
10/2003
1Staphylococcal Protein A (Protein A)IBA
10/2003
1Peptide Hydrolases (Proteases)FDA Link
10/2003
1Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
01/2003

Therapy/Procedure

1Therapeutics
05/2009